Microarray analysis of differentially expressed genes in cells resistant to HIV-1

Immunology Letters

Volumn 93, Issue 1, 2004, Pages 79-86

  Kartvelishvili, Alex ^a   Lesner, Adam ^a   Szponar, Magdalena ^a   Simm, Malgorzata ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Acquired resistance to HIV 1; cDNA arrays; Differentially expressed genes

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; PROTEIN KIAA0117; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; R FACTOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROBE; UPREGULATION; VIRUS RESISTANCE; VIRUS TRANSCRIPTION;

BLOTTING, NORTHERN; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIV-1; HUMANS; IMMUNITY, NATURAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 2342486631     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.02.009     Document Type: Article

References (42)

1. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270(5243):1995;1811- 1815
2. Deng H.K., Unutmaz D., KewalRamani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 388(6639):1997;296-300
3. Dragic T., Trkola A., Lin S.W., Nagashima K.A., Kajumo F., Zhao L., et al. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J Virol. 72(1):1998;279-285
4. Pal R., Garzino-Demo A., Markham P.D., Burns J., Brown M., Gallo R.C., et al. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science. 278(5338):1997;695-698
5. Zhang L., Yu W., He T., Yu J., Caffrey R.E., Dalmasso E.A., et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. 298(5595):2002;995-1000
6. Simm M., Miller L.S., Durkin H.G., Allen M., Chao W., Lesner A., et al. Induction of secreted human immunodeficiency virus type 1 (HIV-1) resistance factors in CD4-positive T lymphocytes by attenuated HIV-1 infection. Virology. 294(1):2002;1-12
7. Chang T.L., Mosoian A., Pine R., Klotman M.E., Moore J.P. A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J. Virol. 76(2):2002;569-581
8. Chen Y., Dampf D., Chen M., Kulka K., Volsky D.J., Saha K., et al. Dependence of CD8+ T-cell-mediated suppression of HIV type 1 on viral phenotypes and mediation of phenotype-dependent suppression by viral envelope gene and not by beta-chemokines. AIDS Res Hum Retroviruses. 16(2):2000;117-124
9. Mackewicz C.E., Blackbourn D.J., Levy J.A. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA. 92(6):1995;2308-2312
10. Blackbourn D.J., Mackewicz C.E., Barker E., Hunt T.K., Herndier B., Haase A.T., et al. Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals. Proc Natl Acad Sci USA. 93(23):1996;13125-13130
11. Barker E., Bossart K.N., Locher C.P., Patterson B.K., Levy J.A. CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells. J Gen Virol. 77(Pt 12):1996;2953-2962
12. Furci L., Lopalco L., Loverro P., Sinnone M., Tambussi G., Lazzarin A., et al. Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals. AIDS. 16(7):2002;1003-1008
13. Simm M., Pekarskaya O., Potash M.J., Volsky D.J. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors. AIDS Res. Hum. Retroviruses. 16(10):2000;943-952
14. Hossain M.M., Tsuchie H., Detorio M.A., Shirono H., Hara C., Nishimoto A., et al. Interleukin-9 receptor alpha chain mRNA formation in CD8+ T cells producing anti-human immunodeficiency virus type 1 substance(s). Acta Virol. 42(1):1998;47-53
15. Sheeter D., Du P., Rought S., Richman D., Corbeil J. Surface CD4 expression modulated by a cellular factor induced by HIV type 1 infection. AIDS Res. Hum. Retroviruses. 19(2):2003;117-123
16. Marzio P.D., Sherry B., Thomas E.K., Franchin G., Schmidtmayerova H., Bukrinsky M. beta-Chemokine production in CD40L-stimulated monocyte-derived macrophages requires activation of MAPK signaling pathways. Cytokine. 23(3):2003;53-63
17. Simm M., Su Z., Huang E.Y., Chen Y., Jiang H., Volsky D.J., et al. Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid subtraction hybridization, RaSH. Gene. 269(1-2):2001;93-101
18. Su Z.Z., Chen Y., Kang D.C., Chao W., Simm M., Volsky D.J., et al. Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene. 306:2003;67-78
19. Wang Z., Pekarskaya O., Bencheikh M., Chao W., Gelbard H.A., Ghorpade A., et al. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology. 312(1):2003;60-73
20. Sgarbanti M., Borsetti A., Moscufo N., Bellocchi M.C., Ridolfi B., Nappi F., et al. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J Exp Med. 195(10):2002;1359-1370
21. Battistini A., Marsili G., Sgarbanti M., Ensoli B., Hiscott J. IRF regulation of HIV-1 long terminal repeat activity. J Interferon Cytokine Res. 22(1):2002;27-37
22. Hodge D.R., Robinson L., Watson D., Lautenberger J., Zhang X.K., Venanzoni M., et al. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation. Oncogene. 12(1):1996;11-18
23. Bovolenta C., Camorali L., Lorini A.L., Ghezzi S., Vicenzi E., Lazzarin A., et al. Constitutive activation of STATs upon in vivo human immunodeficiency virus infection. Blood. 94(12):1999;4202-4209
24. Uddin S., Lekmine F., Sassano A., Rui H., Fish E.N., Platanias L.C. Role of Stat5 in Type I interferon-signaling and transcriptional regulation. Biochem Biophys Res Commun. 308(2):2003;325-330
25. Zolotukhin A.S., Felber B.K. Nucleoporins nup98 and nup214 participate in nuclear export of human immunodeficiency virus type 1 Rev. J Virol. 73(1):1999;120-127
26. Harel A., Forbes D.J. Welcome to the nucleus: can I take your coat? Nat. Cell Biol. 3(12):2001;E267-E269
27. Trotman L.C., Mosberger N., Fornerod M., Stidwill R.P., Greber U.F. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1*. Nat Cell Biol. 3(12):2001;1092-1100
28. Moriuchi M., Moriuchi H., Margolis D.M., Fauci A.S. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. J Immunol. 162(10):1999;5986-5992
29. Hioe C.E., Chien P.C. Jr., Lu C., Springer T.A., Wang X.H., Bandres J., et al. LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission. J Virol. 75(2):2001;1077-1082
30. Sanders R.W., de Jong E.C., Baldwin C.E., Schuitemaker J.H., Kapsenberg M.L., Berkhout B. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J Virol. 76(15):2002;7812-7821
31. Schaefer T.M., Bell I., Pfeifer M.E., Ghosh M., Trible R.P., Fuller C.L., et al. The conserved process of TCR/CD3 complex down-modulation by SIV Nef is mediated by the central core, not endocytic motifs. Virology. 302(1):2002;106-122
32. Sliva D., Zhu Y.X., Tsai S., Kamine J., Yang Y.C. Tip60 interacts with human interleukin-9 receptor alpha-chain. Biochem. Biophys. Res. Commun. 263(1):1999;149-155
33. Parra E., Mustelin T., Dohlsten M., Mercola D. Identification of a CD28 response element in the CD40 ligand promoter. J Immunol. 166(4):2001;2437-2443
34. Dunn K.L., Davie J.R. The many roles of the transcriptional regulator CTCF. Biochem Cell Biol. 81(3):2003;161-167
35. Dunn K.L., Zhao H., Davie J.R. The insulator binding protein CTCF associates with the nuclear matrix. Exp Cell Res. 288(1):2003;218-223
36. Nagase T., Miyajima N., Tanaka A., Sazuka T., Seki N., Sato S., et al. Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res. 2(1):1995;37-43
37. Diaz L.S., Stone M.R., Mackewicz C.E., Levy J.A. Differential gene expression in CD8+ cells exhibiting noncytotoxic anti-HIV activity. Virology. 311(2):2003;400-409
38. Hager G., Eckert E., Schwaiger F.W. Semiquantitative analysis of low levels of mRNA expression from small amounts of brain tissue by nonradioactive reverse transcriptase-polymerase chain reaction. J Neurosci Methods. 89(2):1999;141-149
39. Hu H.Z., Li G.L., Lim Y.K., Chan S.H., Yap E.H. Kinetics of interferon-gamma secretion and its regulatory factors in the early phase of acute graft-versus-host disease. Immunology. 98(3):1999;379-385
40. Filipova G., Fagerlie S., Klenova E., Myers C., Dehner Y., Goodwin G., et al. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol. Cell Biol. 16(6):1996;2802-2813
41. Cha Y., Deisseroth A.B. Human interferon regulatory factor 2 gene. Intron-exon organization and functional analysis of 5′-flanking region. J Biol Chem. 269(7):1994;5279-5287
42. Polack A., Strobl L., Feederle R., Schweizer M., Koch E., Eick D., et al. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift. Oncogene. 6(11):1991;2033-2040